1 郜琨,张斌,陈明迪,等. 血清IL-6、PCT、CRP联合检测对脓毒症患者病情及预后的预测价值[J]. 山东医药,2016,56(24):89-91. 2 Wong DM,Ruby RE,Dembek KA,et al.Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates[J]. J Vet Intern Med,2018,32(3):1185-1193. 3 Rello J,van Engelen TSR,Alp E,et al. Towards Precision Medicine in Sepsis:a position paper from the European Society of Clinical Microbiology and Infectious Diseases[J]. Clin Microbiol Infect,2018,24(12):1264-1272. 4 Kumar N,Dayal R,Singh P,et al.A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis[J].Indian J Pediatr,2019,86(2):177-179. 5 Hutchins N A,Unsinger J,Hotchkiss R S,et al.The new normal:immunomodulatory agents against sepsis immune suppression[J]. Trends Mol Med,2014,20(4):224-233. 6 Fathi M,Markazi-Moghaddam N,Ramezankhani A.A systematic review on risk factors associated with sepsis in patients admitted to intensive care units[J]. Aust Crit Care,2019,32(32):155-164. 7 Chao C M,Lai C C,Chan KS,et al.Outcomes of patients with severe influenza infection admitted to intensive care units:a retrospective study in a medical centre[J]. J Med Microbiol,2017,66(10):1421-1428. 8 Halldorsdottir H D,Eriksson J,Persson B P,et al.Heparin-binding protein as a biomarker of post-injury sepsis in trauma patients[J]. Acta Anaesthesiol Scand,2018,62(7):962-973. 9 Goldstein B,Giroir B,Randolph A,et al.International pediatric sepsis consensus conference:definitions for sepsis and organ dysfunction in pediatrics[J].Pediatr Crit Care Med,2005,6(1):2-8. 10 Bone RC,Grodzin CJ,Balk RA.Sepsis:a new hypothesis for pathogenesis of the disease process[J].Chest,1997,112(1):235-243. 11 Zhou S,Wang G,Zhang W.Effect of TLR4/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats,via regulation of macrophage activation and inflammatory response[J].Exp Ther Med,2018,15(4):3376-3384. 12 赵永祯,李春盛.生物标志物组合对急诊脓毒症和重度脓毒症患者的诊断价值[J]. 中华危重病急救医学,2014,26(3):153-158. 13 姚咏明,栾樱译.客观评价脓毒症生物标志物的临床意义[J].中国危重病急救医学,2012,24(9):517-519 14 查君敬,黄利娟,方长太,等.脓毒症患者血清白细胞介素-6、降钙素原及C-反应蛋白与SOFA 评分的相关性[J].实用医学杂志,2015,31(22):3738-3740. 15 Novotny A R,Reim D,Assfalg V,et al.Mixed antagonist response and sepsis severity-dependent dysbalance of pro-and anti-inflammatory responses at the onset of postoperative sepsis[J].Immunobiology,2012,217(6):616-621. 16 Karpurapu M,Lee YG,Qian Z,et al.Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis[J].Oncotarget,2018,9(12):10606-10620. 17 Claxton AN,Dark PM.Biomarker-guided antibiotic cessation in sepsis:evidence and future challenges[J].Br J Hosp Med (Lond),2018,79(3):136-141. 18 Lu C X,Qiu T,Tong H S,et al.Peripheral T-lym-phocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis[J].Exp Ther Med,2016,11(3):1077-1084. 19 陈勇,何文杰,陈立华. 降钙素原与C反应蛋白在细菌感染诊断中的作用[J].中国医师杂志,2013,15(11):1511-1514. 20 王胜云,陈德昌. 降钙素原和C-反应蛋白与脓毒症患者病情严重程度评分的相关性研究及其对预后的评估价值[J]. 中华危重病急救医学,2015,27(2):97-101. |